Lawson Kroeker Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.21M | Sell |
174,686
-16,172
| -8% | -$423K | 1.17% | 30 |
|
|
2026
Q1 | $5.36M | Sell |
190,858
-1,913
| -1% | -$50.9K | 1.56% | 24 |
|
|
2025
Q4 | $4.8M | Sell |
192,771
-8,895
| -4% | -$224K | 1.43% | 26 |
|
|
2025
Q3 | $5.14M | Sell |
201,666
-5,985
| -3% | -$148K | 0.94% | 35 |
|
|
2025
Q2 | $5.03M | Sell |
207,651
-2,275
| -1% | -$53.1K | 0.94% | 35 |
|
|
2025
Q1 | $5.32M | Sell |
209,926
-850
| -0.4% | -$22.2K | 0.98% | 34 |
|
|
2024
Q4 | $5.59M | Sell |
210,776
-7,535
| -3% | -$204K | 1.05% | 33 |
|
|
2024
Q3 | $6.32M | Sell |
218,311
-4,350
| -2% | -$127K | 1.15% | 29 |
|
|
2024
Q2 | $6.23M | Sell |
222,661
-80
| -0% | -$2.2K | 1.2% | 30 |
|
|
2024
Q1 | $6.33M | Sell |
222,741
-7,835
| -3% | -$217K | 1.2% | 30 |
|
|
2023
Q4 | $6.64M | Sell |
230,576
-10,216
| -4% | -$309K | 1.36% | 29 |
|
|
2023
Q3 | $7.99M | Buy |
240,792
+1,275
| +0.5% | +$45.1K | 1.76% | 21 |
|
|
2023
Q2 | $8.79M | Buy |
239,517
+1,725
| +0.7% | +$67.1K | 2.11% | 17 |
|
|
2023
Q1 | $9.7M | Sell |
237,792
-7,850
| -3% | -$339K | 2.18% | 16 |
|
|
2022
Q4 | $12.6M | Sell |
245,642
-275
| -0.1% | -$13.2K | 4.25% | 4 |
|
|
2022
Q3 | $10.8M | Sell |
245,917
-100
| -0% | -$4.86K | 3.78% | 6 |
|
|
2022
Q2 | $12.9M | Sell |
246,017
-23,450
| -9% | -$1.19M | 4.35% | 4 |
|
|
2022
Q1 | $13.9M | Sell |
269,467
-500
| -0.2% | -$25.9K | 4.39% | 5 |
|
|
2021
Q4 | $15.9M | Sell |
269,967
-752
| -0.3% | -$37.3K | 4.95% | 4 |
|
|
2021
Q3 | $11.6M | Sell |
270,719
-6,985
| -3% | -$309K | 3.86% | 7 |
|
|
2021
Q2 | $10.9M | Sell |
277,704
-2,440
| -0.9% | -$94.9K | 3.44% | 8 |
|
|
2021
Q1 | $10.2M | Sell |
280,144
-545
| -0.2% | -$19.4K | 3.47% | 8 |
|
|
2020
Q4 | $10.3M | Sell |
280,689
-16,390
| -6% | -$601K | 3.87% | 6 |
|
|
2020
Q3 | $10.3M | Buy |
297,079
+10,945
| +4% | +$384K | 4.61% | 5 |
|
|
2020
Q2 | $8.88M | Sell |
286,134
-316
| -0.1% | -$10.7K | 4.19% | 7 |
|
|
2020
Q1 | $8.87M | Buy |
286,450
+432
| +0.2% | +$14.7K | 4.93% | 4 |
|
|
2019
Q4 | $10.6M | Sell |
286,018
-4,484
| -2% | -$160K | 3.93% | 8 |
|
|
2019
Q3 | $9.9M | Sell |
290,502
-23,347
| -7% | -$849K | 3.77% | 9 |
|
|
2019
Q2 | $12.9M | Sell |
313,849
-1,159
| -0.4% | -$46K | 4.33% | 5 |
|
|
2019
Q1 | $12.7M | Sell |
315,008
-5,644
| -2% | -$226K | 4.53% | 4 |
|
|
2018
Q4 | $13.3M | Sell |
320,652
-3,507
| -1% | -$146K | 5.21% | 2 |
|
|
2018
Q3 | $13.6M | Sell |
324,159
-674
| -0.2% | -$25.9K | 4.4% | 3 |
|
|
2018
Q2 | $11.2M | Sell |
324,833
-1,165
| -0.4% | -$39.8K | 3.98% | 5 |
|
|
2018
Q1 | $11M | Sell |
325,998
-643
| -0.2% | -$22.1K | 3.59% | 9 |
|
|
2017
Q4 | $11.2M | Sell |
326,641
-25,745
| -7% | -$878K | 3.61% | 9 |
|
|
2017
Q3 | $11.9M | Sell |
352,386
-1,354
| -0.4% | -$43.5K | 3.76% | 6 |
|
|
2017
Q2 | $11.3M | Sell |
353,740
-3,686
| -1% | -$116K | 3.78% | 7 |
|
|
2017
Q1 | $11.6M | Sell |
357,426
-1,660
| -0.5% | -$52.3K | 3.93% | 5 |
|
|
2016
Q4 | $11.1M | Sell |
359,086
-53,227
| -13% | -$1.62M | 3.8% | 5 |
|
|
2016
Q3 | $13.3M | Sell |
412,313
-185
| -0% | -$6.19K | 4.28% | 3 |
|
|
2016
Q2 | $13.8M | Sell |
412,498
-2,266
| -0.5% | -$72.3K | 4.57% | 2 |
|
|
2016
Q1 | $11.7M | Sell |
414,764
-2,672
| -0.6% | -$76.3K | 4.01% | 6 |
|
|
2015
Q4 | $12.8M | Sell |
417,436
-16,742
| -4% | -$527K | 4.42% | 5 |
|
|
2015
Q3 | $12.9M | Sell |
434,178
-5,892
| -1% | -$189K | 4.34% | 5 |
|
|
2015
Q2 | $14M | Sell |
440,070
-1,133
| -0.3% | -$36.9K | 4.15% | 4 |
|
|
2015
Q1 | $14.6M | Sell |
441,203
-1,371
| -0.3% | -$43.6K | 4.24% | 4 |
|
|
2014
Q4 | $13.1M | Sell |
442,574
-26
| -0% | -$746 | 4.11% | 3 |
|
|
2014
Q3 | $12.4M | Sell |
442,600
-1,112
| -0.3% | -$31.2K | 3.71% | 7 |
|
|
2014
Q2 | $12.5M | Buy |
443,712
+3,786
| +0.9% | +$108K | 3.64% | 6 |
|
|
2014
Q1 | $13.4M | Buy |
439,926
+2,846
| +0.7% | +$84.9K | 4.19% | 4 |
|
|
2013
Q4 | $12.7M | Sell |
437,080
-4,058
| -0.9% | -$118K | 4.03% | 4 |
|
|
2013
Q3 | $12M | Sell |
441,138
-2,793
| -0.6% | -$76K | 4% | 3 |
|
|
2013
Q2 | $11.8M | Buy |
+443,931
| New | +$12.3M | 4.12% | 2 |
|
Other funds holding PFE
AIM
SLAM
CWP
Lawson Kroeker Investment Management's PFE Position: Q2 2026 in Review
Lawson Kroeker Investment Management reduced its Pfizer (PFE) stake by 8.5% in Q2 2026, selling an estimated $423K and leaving 174,686 shares worth $4.21M. The position accounts for 1.17% of the portfolio, ranked #30.
Lawson Kroeker Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.9M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Lawson Kroeker Investment Management held 174,686 shares of Pfizer worth $4.21M as of Q2 2026.
- Lawson Kroeker Investment Management sold 16,172 Pfizer shares in Q2 2026, an estimated $423K.
- Pfizer made up 1.17% of Lawson Kroeker Investment Management's portfolio in Q2 2026, its #30 holding.
- Lawson Kroeker Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Lawson Kroeker Investment Management's Pfizer position peaked at $15.9M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Lawson Kroeker Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.